In summary, this study has successfully identified a DNAm episignature for PTHS, facilitating molecular testing and the reclassification of TCF4 VUSs in individuals exhibiting signs of PTHS without the requirement additional tissue analyses. Here, TCF4 is linked to Pitt-Hopkins syndrome.